标普和纳斯达克内在价值 联系我们

M3, Inc. MTHRY OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • JP • USD

SharesGrow Score
79/100
4/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

M3, Inc. (MTHRY) 当前追踪市盈率 (P/E) 为 0.2. 追踪盈利收益率为 588.24%.

本页证实的标准:

  • VALUE (100/100, 通过) — 市盈率低于市场平均水平 (0.2); 盈利收益率超过债券收益率 (588.24%).
  • 追踪盈利收益率 588.24% — 超过典型债券收益率(约4.3%),使股票相对固定收益更具吸引力。

SharesGrow 综合评分: 77/100 其中 4/7 项标准通过。

SharesGrow 7-Criteria Score
79/100
SG Score
View full scorecard →
价值
100/100
Price-to-Earnings & upside
Proven by this page
未來
N/A
No coverage
过去
100/100
→ Income
健康
100/100
Debt-to-Equity & liquidity
→ Health
护城河
73/100
→ Income
~
成长
48/100
→ Income
~
收入
55/100
→ Income

估值概览 — MTHRY

估值倍数
P/E (TTM)0.2
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.02
EV/EBITDA0.0
每股数据
EPS (TTM)$29.80
每股账面价值$0.00
每股营收$209.72
每股自由现金流$0.00
收益率与内在价值
盈利收益率588.24%
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2016 $9.65 $64.66B $12.51B 19.3%
2017 $12.35 $78.14B $16B 20.5%
2018 $13.99 $94.47B $18.13B 19.2%
2019 $15.10 $113.06B $19.58B 17.3%
2020 $15.94 $130.97B $21.64B 16.5%
2021 $27.84 $169.2B $37.82B 22.4%
2022 $46.99 $208.16B $63.85B 30.7%
2023 $36.09 $230.82B $49.03B 21.2%
2024 $33.32 $238.88B $45.27B 19%
2025 $29.80 $284.9B $40.48B 14.2%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言